Securities fraud litigation history and active cases
In Litigation
1
Settlement
0
Closed
1
Total Settlement
$0
1:26cv11510 • March 30, 2026
Class Period Start
November 3, 2023
Class Period End
March 16, 2026
PSLRA Deadline
May 29, 2026
Case Allegations
10b5
Statutes of Repose
Nov 3, 2026
Country
United States
Court
Federal Court
Oct 9, 2026
A new complaint has been filed on behalf of certain investors in Aldeyra Therapeutics, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Aug 10, 2026
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
1:23cv11737 • July 31, 2023
Class Period Start
January 7, 2021
Class Period End
October 16, 2023
PSLRA Deadline
September 29, 2023
Case Allegations
10b5
Statutes of Repose
Jan 7, 2024
Country
United States
Court
Federal Court
Mar 14, 2025
Motion to Dismiss Granted
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
Mar 4, 2024
Motion to Dismiss
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
TOP